UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033179
Receipt number R000037692
Scientific Title Magnetic resonance imaging evaluation of permeability of inner ear with endolymphatic hydrops
Date of disclosure of the study information 2018/09/01
Last modified on 2023/07/03 05:45:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Magnetic resonance imaging evaluation of permeability of inner ear with endolymphatic hydrops

Acronym

Permeability of inner ear with endolymphatic hydrops

Scientific Title

Magnetic resonance imaging evaluation of permeability of inner ear with endolymphatic hydrops

Scientific Title:Acronym

Permeability of inner ear with endolymphatic hydrops

Region

Japan


Condition

Condition

endolymphatic hydrops and related disease

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the permeability of inner ear with endolymphatic hydrops and related disease

Basic objectives2

Others

Basic objectives -Others

To evaluate the endolymphatic hydrops

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

the permeability of inner ear

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

MRI

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

endolymphatic hydrops and related disease

Key exclusion criteria

Asthma
impairment of renal function
allergy of contrast agent

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Michihiko
Middle name
Last name Sone

Organization

Nagoya university

Division name

Otorhinolarungology

Zip code

4668550

Address

65, tsurumai-cho, showa-ku, nagaya

TEL

052-744-2323

Email

michsone@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Tadao
Middle name
Last name Yoshida

Organization

Nagoya university

Division name

Otorhinolarungology

Zip code

4668550

Address

65, tsurumai-cho, showa-ku, nagaya

TEL

052-744-2323

Homepage URL


Email

tadaoy@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya university

Institute

Department

Personal name



Funding Source

Organization

Nagoya university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Graduate School of Medicine

Address

65, tsurumai, showa-ku, Nagoya

Tel

052-744-2111

Email

tadaoy@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 06 Month 27 Day

Date of IRB

2018 Year 10 Month 24 Day

Anticipated trial start date

2018 Year 09 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 06 Month 28 Day

Last modified on

2023 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037692


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name